Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Test Kit Detects Melamine In Infant Formula And Other Food
Larry Wackett and Michael Sadowsky, members of the University of Minnesota"s BioTechnology Institute, developed an enzyme that is used in Bioo Scientific"s new MaxDiscovery™ Melamine Test kit, which simplifies the detection of melamine contamination in food. Melamine is an industrial chemical that killed six Chinese children and hospitalized 150,000 last year after it was added to milk to increase its apparent protein content. Some children may have life-long chronic kidney problems resulting from melamine exposure.
generic viagra online
Construction Firms Warned Not To Put Lives In Danger After Builder Is Left Paralysed, UK
The Health and Safety Executive (HSE) is reminding construction companies of their duties to employees after a worker was paralysed in a fall.
News of the day
13th World Conference On Lung Cancer Focuses On Advanced Targeted Therapies Effective As First-Line Treatment
The world"s top lung cancer specialists, medical professionals and researchers are convening this week in San Francisco, CA for the 13th World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC). According to a series of studies presented today at the WCLC, targeted therapies, as first-line treatment, have the potential to slow cancer growth and improve patient outcomes. Unlike traditional chemotherapy-based treatments, which destroy cancerous and non-cancerous cells alike, targeted therapies are designed to inhibit only cancer cell replication and tumor growth and are generally well tolerated by patients.
Endocrinology

Dr. David Fischell To Speak At The EuroPCR Conference In Barcelona On The Detection Of Plaque Rupture With The AngelMed Guardian System.

Angel Medical Systems has announced that Dr. David Fischell, Chief Executive Officer, will be the first featured speaker at the upcoming Out-of-the-box "Session Innovation@EuroPCR09" on May 19 in Barcelona, Spain. EuroPCR is the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Dr. Fischell"s presentation will highlight data from recent human clinical studies showing the AngelMed Guardian System"s ability to detect vulnerable plaque rupture. "When someone has a heart attack, it is typically the result of a blood clot closing one of the three major coronary arteries. When this happens, there is a shift in the ST segment of the heart signal caused by the electrical difference between the portion of the heart muscle fed by the closed artery and the rest of the heart that is still receiving oxygen," says Dr. Fischell. The Guardian System is designed to internally monitor ECG signals in real time, 24-hours-a-day, to detect these ST shifts resulting from coronary occlusions. The System is comprised of an internal implantable device about the size of a pacemaker with a single pacemaker lead into the heart, an external pager-like alerting device, and a programmer that lets physicians read out the heart signals. Early clinical cases have shown the Guardian System"s ability to detect plaque ruptures in patients and warn them to seek immediate medical attention. "Experimental and clinical studies have shown that most of the damage to the heart occurs during the first two hours after coronary occlusion," adds Dr. Fischell. "This device has the potential to warn patients hours--perhaps even days--before a heart attack occurs." The Guardian System is currently available commercially in Brazil, and is in the ALERTS Phase II Pivotal trial in clinical sites across the United States. The first implants in the ALERTS trial took place in December, 2008 with sites across more than 10 states now enrolling patients in the study. Angel Medical is currently ISO 13485 certified and is working with a notified body to gain CE mark approval. Angel Medical Systems


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009